Actively Recruiting
Studies on Long-term Survivorship of Discharged Patients With Malignant Tumor Based on Fudan University Shanghai Cancer Center Registry
Led by Fudan University · Updated on 2021-08-09
500000
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research focuses on patients who have undergone anti-tumor treatments while hospitalized for malignant tumors. It aims to observe long-term outcomes such as overall survival and disease-free survival in a real-world setting, using data from a hospital-based cancer registry in China. The study explores factors influencing cancer survival from both clinical and socio-economic perspectives. Participants include patients treated with surgery, radiotherapy, chemotherapy, or immunotherapy during their hospital stay. The study collects data continuously at a single center, grouping patients by cancer site, and follows them over time to gather survival information. Follow-up involves reviewing medical records, telephone interviews, and linking data to provincial death certificate registries. Researchers measure overall survival and disease-free survival over a 15-year period to provide valuable long-term data on cancer prognosis. The study began in 2008 and will continue through 2041.
CONDITIONS
Brief Title
Long-term Survivorship of Discharged Patients With Malignant Tumor Based on Single-institutional Cancer Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Completed tumor treatment including surgery, radiotherapy, chemotherapy, or immunotherapy during hospitalization
- Diagnosed with malignant tumors confirmed before or during surgery
- Treatment received at Fudan University Shanghai Cancer Center during the study period
You will not qualify if you...
- Patients who have not received any tumor treatment during hospitalization
- Patients diagnosed with non-malignant tumors only
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
screening and enrollment visit
Duration - Up to 15 years
Participants who have completed tumor treatment including surgery, radiotherapy, chemotherapy, or immunotherapy during hospitalization are observed for overall and disease-free survival.
Follow-up through medical records review, telephone call interviews, and data linkage to death registries
Trial Site Locations
Total: 1 location
1
Fudan University Shanghai Cancer Center
Shanghai, China
Actively Recruiting
Research Team
Y
Ying Zheng, Dr.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here